-
Recent Posts
- Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) Spikes with Promise of Tasimelteon
- Is Enviro-Serv, Inc. (PINKSHEETS: EVSV) Any Closer to Generating Revenues?
- Eagle Bulk Shipping, Inc. (NASDAQ: EGLE) Spikes on Earnings but is there More to the Numbers?
- Is Gold in the Future for FBC Holding, Inc. (OTCQB: FBCD)?
- Will it be Clear Sailing for Alas International Holdings, Inc. (PINKSHEETS: VDSC)?
Categories
OTC Equity Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
Tags
aapl advertising alternative energy amex apple basic materials biopharmaceutical biotechnology cancer capital goods cloud computing copper drilling energy energy stocks exploration facebook fda fda approval gas gold gold mining google healthcare stocks investors ipad iphone mining NASDAQ natural gas nyse oil oil and gas otcbb penny stock penny stocks petroleum pharmaceutical pinksheets Pink Sheets s silver sprint stocks tradingSite
OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
Registration to our newsletter is FREE, Join today by entering your email below!
Tag Archives: hpv
Can Inovio Pharmaceuticals, Inc. (AMEX: INO) Realize Potential with Multiple Synthetic Vaccines for Wide Range of Medical Issues?
After starting the month of November strong with a share price that hit 0.7200 Inovio Pharmaceuticals, Inc. (AMEX: INO) hit a snag and slipped as low as 0.4400 but the biotechnology company has been posting some pretty impressive numbers of … Continue reading
Posted in AMEX, Articles
Tagged biotechnology, cancer, cmv, hiv, hpv, ino, inovio pharmaceuticals, investors, medical issues, virus
Leave a comment
How Much Longer Can Allezoe Medical Holdings (OTCBB: ALZM) Promote Promise of LifeCradle without Plan for FDA Approval?
At some point Allezoe Medical Holdings (OTCBB: ALZM) is going to have to stop talking about their potential and start delivering revenue, or at least give a sign that they’re taking steps to generate revenue, if they want to keep … Continue reading
Posted in Uncategorized
Tagged allezoe medical, alzm, fda, hpv, investors, lifecradle, organ transplant, penny stocks, transplant centers
Leave a comment
Allezoe Medical Holdings, Inc. (OTCBB: ALZM) Acquires Diagnostic Technology for HPV but FDA Approval Remains a Hurdle Yet to be Cleared
With Allezoe Medical Holdings, Inc. (OTCBB: ALZM) announcing on Tuesday that they had acquired the exclusive license to develop and market patent pending, advanced “see and treat” diagnostic technology for Human papillomavirus (HPV), the world’s leading sexually transmitted infection, trading … Continue reading
Posted in Uncategorized
Tagged allezoe medical, alzm, cancer, fda, fda approval, hpv, human organ, investors, lifecradle, otcbb, penny stocks
Leave a comment
Allezoe Medical Holdings, Inc. (OTCBB: ALZM) Finding it Hard to Convince Investors about HPV Technology while LifeCradle Technology Remains on Life Support
Investors that are considering taking a position in Allezoe Medical Holdings, Inc. (OTCBB: ALZM) based on their recent announcements detailing their agreement to acquire patent pending technology that would enable healthcare providers to “see and treat” Human Papillomavirus (HPV) and … Continue reading
Posted in Uncategorized
Tagged allezoe, alzm, fda, fda approval, hpv, hpv vaccine, investors, lifecradle, organ transplant, otcbb, penny stocks
Leave a comment


